Education
About Us
Working with TipRanks
Follow Us
Suven Pharmaceuticals Ltd. (IN:COHANCE)
:COHANCE
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 11.98B | ₹ 10.51B | ₹ 13.40B | ₹ 13.20B | ₹ 10.10B |
| Gross Profit | ₹ 8.22B | ₹ 6.80B | ₹ 7.52B | ₹ 7.46B | ₹ 5.73B |
| Operating Income | ₹ 5.66B | ₹ 5.40B | ₹ 6.30B | ₹ 6.33B | ₹ 4.83B |
| EBITDA | ₹ 4.06B | ₹ 4.09B | ₹ 5.73B | ₹ 5.79B | ₹ 4.41B |
| Net Income | ₹ 2.68B | ₹ 3.00B | ₹ 4.11B | ₹ 4.54B | ₹ 3.62B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 2.90B | ₹ 8.21B | ₹ 4.84B | ₹ 5.26B | ₹ 1.88B |
| Total Assets | ₹ 30.32B | ₹ 22.54B | ₹ 19.66B | ₹ 18.30B | ₹ 14.74B |
| Total Debt | ₹ 2.79B | ₹ 649.96M | ₹ 703.41M | ₹ 971.27M | ₹ 1.43B |
| Net Debt | ₹ 1.94B | ₹ 177.65M | ₹ 55.38M | ₹ 525.63M | ₹ 1.36B |
| Total Liabilities | ₹ 11.91B | ₹ 2.03B | ₹ 2.31B | ₹ 3.02B | ₹ 2.94B |
| Stockholders' Equity | ₹ 16.97B | ₹ 20.51B | ₹ 17.35B | ₹ 15.27B | ₹ 11.81B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 1.32B | ₹ 3.07B | ₹ 1.65B | ₹ 2.55B | ₹ 2.73B |
| Operating Cash Flow | ₹ 2.88B | ₹ 3.58B | ₹ 4.51B | ₹ 3.30B | ₹ 3.83B |
| Investing Cash Flow | ₹ -2.55B | ₹ -3.62B | ₹ -1.95B | ₹ -1.36B | ₹ -3.11B |
| Financing Cash Flow | ₹ 33.20M | ₹ -138.02M | ₹ -2.36B | ₹ -1.56B | ₹ -765.53M |